Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment

Rambam Health Care Campus70 enrolled

Overview

To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and prognosis, for optimized tailoring of the therapeutic strategy in the individual patient.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pancreatic Cancer

Interventions

PET-CTDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age\>18 * newly diagnosed untreated aggressive NHL * newly diagnosed untreated cancer of pancreas Exclusion Criteria: * none

Locations (1)

Rambam Medical Center

Haifa, Israel

Outcomes

Primary Outcomes

The impact of the imaging modality on patient management

Time frame: 5 years

Secondary Outcomes

patient management

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.